Dr. Bijoy Telivala, M.D.
What this data tells you about Dr. Telivala
Dr. Bijoy Telivala is a hematology & oncology in Jacksonville, FL, with 17 years in practice. Based on federal Medicare data, Dr. Telivala performed 66,545 Medicare services across 2,256 unique beneficiaries.
Between the years covered by Open Payments, Dr. Telivala received a total of $3,398 from 27 pharmaceutical and/or device companies across 54 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Telivala is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) | 41,250 | $1 | $4 |
| Contrast dye for imaging (iodine-based) | 11,700 | $0 | $1 |
| Epoetin alfa injection (Retacrit) for anemia | 4,000 | $6 | $27 |
| Dexamethasone injection (steroid) | 1,668 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 1,620 | $18 | $38 |
| Blood draw (venipuncture) | 990 | $8 | $18 |
| Complete blood count (CBC) with differential | 986 | $8 | $41 |
| Injection, granisetron hydrochloride, 100 mcg | 510 | $0 | $41 |
| Office visit, established patient (20-29 min) | 478 | $63 | $104 |
| Office visit, established patient (30-39 min) | 372 | $96 | $162 |
| MRI contrast dye injection (gadoterate) | 359 | $0 | $25 |
| Anti-nausea injection (Aloxi/palonosetron) | 340 | $1 | $75 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 313 | $22 | $90 |
| Drug injection, under skin or into muscle | 241 | $10 | $42 |
| Administration of chemotherapy into vein, 1 hour or less | 205 | $98 | $355 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 159 | $135 | $2,250 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 128 | $46 | $160 |
| Hospital follow-up visit, moderate complexity | 126 | $62 | $115 |
| Ct scan of chest with contrast | 91 | $50 | $500 |
| CT scan of abdomen and pelvis with contrast | 86 | $169 | $535 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 80 | $1,065 | $2,400 |
| Injection, diphenhydramine hcl, up to 50 mg | 78 | $1 | $4 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 76 | $385 | $1,000 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 75 | $15 | $55 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 75 | $24 | $84 |
| Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | 70 | $72 | $70 |
| Blood creatinine level | 67 | $5 | $29 |
| Administration of chemotherapy into vein, each additional hour | 66 | $22 | $80 |
| Injection of additional new drug or substance into vein | 43 | $12 | $55 |
| Infusion, normal saline solution , 1000 cc | 42 | $2 | $97 |
| Initial hospital admission, moderate complexity | 40 | $103 | $225 |
| New patient office visit (45-59 min) | 37 | $129 | $265 |
| CT scan of chest, without contrast | 35 | $41 | $310 |
| Infusion into a vein for hydration, 31-60 minutes | 33 | $24 | $130 |
| Ct scan of abdomen and pelvis without contrast | 25 | $74 | $270 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 25 | $1 | $7 |
| Infusion into a vein for hydration, each additional hour | 19 | $9 | $40 |
| Nuclear medicine study whole body with ct scan | 14 | $1,092 | $2,490 |
| Biopsy of bone marrow | 12 | $124 | $407 |
| Initial hospital admission, high complexity | 11 | $137 | $330 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (77%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
5.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Telivala is a mixed practice specialist, with above-average Medicare volume (top 13% in FL), and speaking/promotional industry engagement, with 17 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Telivala experienced with iron infusion (injectafer)?
Does Dr. Telivala receive payments from pharmaceutical companies?
How do Dr. Telivala's costs compare to other hematology & oncologys in Jacksonville?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology